SCIENTURE Announces Issuance of Orange Book-Listable Patent Covering REZENOPY(TM), the Highest Dosage Naloxone HCl Nasal Spray Approved by the FDA for Life-Saving Opioid Overdose Emergency Treatment

(NASDAQ:SCNX), U.S. Naloxone Market: ~$154 million in annual sales and 9.3 million units annually COMMACK, NY, Jan. 14, 2026 (GLOBE NEWSWIRE) — SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through the development, commercialization, and distribution of novel […]

Constructor Wins ‘Retail & Ecommerce’ Category in Global AI Awards

Judges recognize Constructor’s AI platform for improving shopping experiences and driving ecommerce growth Constructor, the leading AI-powered search and product discovery platform for enterprise ecommerce companies, is a winner in the inaugural Global AI Awards, a program honoring excellence in artificial intelligence. Constructor earned the top honors in the “AI in retail & ecommerce” category

In 2026, Financial Executives Prioritize Technology, AI, and Disciplined Growth for Resilient Performance

FERF’s Financial Executives Priorities 2026 Report Reveals Shift From Planning to Execution as Finance Leaders Accelerate Digital Transformation The Financial Education & Research Foundation (FERF)–the independent nonprofit research affiliate of Financial Executives International (FEI)–today released the findings of its Financial Executives Priorities 2026 Report, revealing how finance leaders are navigating economic uncertainty with disciplined growth

Resolve Pain Solutions Announces Acquisition of Spine Diagnostic & Pain Treatment Center

Resolve Pain Solutions (“Resolve”), a leading provider of comprehensive interventional pain management services, today announced the acquisition of Spine Diagnostic & Pain Treatment Center (“Spine”), a well-established pain management platform with clinic locations serving the greater Baton Rouge, Louisiana, area. As part of the transaction, Resolve is welcoming Spine’s physician and executive leadership, including Dr.

SCIENTURE Announces Issuance of Orange Book-Listable Patent Covering REZENOPY(TM), the Highest Dosage Naloxone HCl Nasal Spray Approved by the FDA for Life-Saving Opioid Overdose Emergency Treatment

SCIENTURE Announces Issuance of Orange Book-Listable Patent Covering REZENOPY(TM), the Highest Dosage Naloxone HCl Nasal Spray Approved by the FDA for Life-Saving Opioid Overdose Emergency Treatment GlobeNewswire January 14, 2026 U.S. Naloxone Market: ~$154 million in annual sales and 9.3 million units annually COMMACK, NY, Jan. 14, 2026 (GLOBE NEWSWIRE) — SCIENTURE HOLDINGS, INC. (NASDAQ:

Zomee Launches New Mother’s Nature(TM) Line, Unveils Most Affordable Warming Wearable Breast Pump

Zomee Launches New Mother's Nature(TM) Line, Unveils Most Affordable Warming Wearable Breast Pump New Mother's Nature(TM) W1 Breast Pump brings warmth, rhythm, and spa-like comfort GlobeNewswire January 14, 2026 POMPANO BEACH, Fla., Jan. 14, 2026 (GLOBE NEWSWIRE) — Moms have long searched for a breast pump that feels natural and closer to breastfeeding, and now,

Mova, Backed by Aqua, Invests in Naoris Protocol to Launch Secure Cards and Payment Infrastructure

ABU-DHABI, United Arab Emirates, Jan. 14, 2026 (GLOBE NEWSWIRE) — Mova, backed by Aqua, today announced a strategic investment in Naoris Protocol, alongside plans to launch secure card and payment infrastructure, embedding decentralised security validation directly into payment and settlement workflows. The investment reflects Mova Chain's commitment to integrating advanced security primitives capable of supporting

Phlow and Enveda Partner to Advance AI-Driven Chemistry to Accelerate Domestic Pharmaceutical Development and Transform Drug Substance Manufacturing

Richmond, Virginia, Jan. 14, 2026 (GLOBE NEWSWIRE) — RICHMOND, Va., January 14, 2026 – Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced a major advancement in AI-driven Active Pharmaceutical Ingredient (API) manufacturing process development in collaboration with Enveda, a biotechnology company that learns from life's chemistry to create better

Scroll to Top